"More skin in the game than anyone else".... There are plenty of...

First 156 Last

Share
Profile

Follow
sulmar

398 Posts.

88

06/12/22

00:51

Post #: 65165397
Share

Originally posted by MickeyMantle536: ↑

Not one of us can predict what the market will do next year. The company has an opportunity to bank $13 million now with a consortium of institutional investors who have a background of supporting healthcare stocks. The board also have an obligation to assess the investment and determine if this is in the best interests of the business.

In answer to your question, I’m excited to see a board that will not cross their fingers and hope it all works out. That’s the sign of a board that is prepared to make difficult decisions when required to ensure the business is funded. Don’t forget the board has more “skin in the game” than anyone. That’s motivation to get the best deal available in these market conditions and yet I’m reading all these armchair director comments from people who’ve enjoyed all the benefits of Joel’s business acumen without any responsibility for managing a $400m company. It’s honestly pathetic and I’ve got zero time for those people.

The investment group has not been disclosed to the market at this point, however I can assure you that if Joel states it’s strategic then it absolutely is. I’ve spent enough time with him to say he’s never going to do a deal that isn’t for the long term benefit of the company. I understand this group has the capacity to provide significant support and future funding where required and a desire to do exactly that. It’s the start of a partnership with the calibre of investors required to deliver an outcome for all shareholders. Retail punters simply don’t have the depth of capital required.

I couldn’t care less if someone sells at these prices because they’re all emotional. Good riddance. And if you think 20.5c was a great deal for the institutions then guess what? You can buy the stock today for that price.

The OSA results are a potential takeover event and if that occurs it will be billions of dollars IMO. If some HC poster can’t work out what the potential is then go find some other stock to punt, no one cares if you sell.

But if the business isn’t funded then all this clinical work is worth nothing. And that’s why I’ll back Joel 100% with this decision even if there’s some short term angst, because I’m invested for dollars not cents.

Expand

"More skin in the game than anyone else".... There are plenty of companies who have BoD that own a big part yet their business has done nothing?

This was a desperate raise because BoD prolly scared since nothing happening in the near future and woulda been even more difficult to raise next year.

IHL Price at posting: 20.5¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The winners & losers on market if negative gearing were gone

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

There are more pages in this discussion • 85 more messages in this thread...

First 156 Last

Add IHL (ASX) to my watchlist

"More skin in the game than anyone else".... There are plenty of...

Top Stories

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

KalGold rolls out detailed aeromagnetic survey across Pinjin project

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

The winners & losers on market if negative gearing were gone

ACCC seeks Olam divestments before it can buy Namoi Cotton

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

The market's shrugged at China's stimulus measures all year. Why is this one different?

Featured News